After 11 years of being online, April 30th 2012 was the last day LifeGen.de published daily news, reports and no-mainstream issues. We’d like to thank our readers for having used our webzine since 2001 as an alternative source of information. A very special “Thanks!” goes to those institutes of the German Max Planck and Fraunhofer Gesellschaft, who have been our subscribers. They supported us by paying subscription fees for almost a decade. We also have to mention our advisory board, whose members have been watching us from an independent point of view without getting any money for their precious help. And last not least we will not forget our editorial staff, which delivered excellent stories, reports and analysis data. Our deep respect belongs to editorial staff member Dr. Rolf Froböse, who has been one of the most active science writers with a profound knowledge in chemical and engineering sciences. Last not least we'd like to thank all institutions and organizations which quoted our articles or published them as a header linking to our site, like the Trust for America’s Health did. The reason we stop publishing is a monetary one. Despite all our efforts we couldn’t get the investor capital needed to expand the webzine to a leading global no-mainstream platform in the web.
Twittern
LifeGen.de was established in 2001 as a private follow up of the state granted portal Lifescience.de, which CEO Vlad Georgescu and Marita Vollborn lead as editorial directors in 2000. LifeGen.de became one of the powerful online platforms in Europe with a high impact on the social media sector. LifeGen.de counted in 2009 more than 300,000 unique users. Our articles and reports have been read by members of the German Bundestag, by domestic or foreign governmental, financial and economic institutions and companies as well as by universities, scientific and medical associations. Almost 10.000 articles can be found on Germany’s biggest economic databank GENIOS.
Among the reports published are articles about the birth control pill YASMIN, reports on the contamination with avian flu viruses by the U.S. company Baxter and background reports on the possible carcinogenic effects of BP's oil spill in the Gulf of Mexico. LifeGen.de focused on risk analysis and political forecasts.
All our articles will remain online, as well as our OSINT and research activities will continue.
Any comments? Write us!
LIFEGEN.DE LTD
483 Green Lanes
London N13 4BS
United Kingdom
email: redaktion(at)lifegen.de
(2012-11-14)
Für den Volltext-Zugang zu unseren Inhalten bitte mit Ihrem Usernamen/Passwort hier einloggen, wenn Sie bereits zahlender Abonnent von LifeGen.de sind. Click-and-Buy Kunden melden sich weiter unten an Passwort vergessen?
Falls Sie kein Abonnent sind, dann können Sie unseren Click-and-Buy Service nutzen.
Bestellen Sie unseren KOSTENLOSEN Newsletter mit dem Nachrichten-Überblick
Sie finden unsere no-mainstream Inhalte gut und möchten die redaktionelle Unabhängigkeit des Magazins LifeGen.de unkompliziert ohne jegliche Bindung unterstützen? Dann spenden Sie einfach den Betrag Ihrer Wahl an die email-Adresse redaktion@lifegen.de, die über das Portal Moneybookers gleichzeitig als virtuelles Konto fungiert. Weitere Informationen zum sicheren Bezahlsystem von Moneybookers finden Sie an dieser Stelle bei Wikipedia.
